Bleichroeder LP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bleichroeder LP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,736,564
-37.0%
755,0280.0%0.43%
-23.4%
Q2 2023$2,755,852
+2.2%
755,0280.0%0.56%
-2.8%
Q1 2023$2,695,450
+9.8%
755,028
-12.3%
0.58%
+7.9%
Q4 2022$2,454,642
+98.3%
861,278
+55.2%
0.53%
+106.6%
Q3 2022$1,238,000
-10.4%
555,0000.0%0.26%
-9.5%
Q2 2022$1,382,000
-48.7%
555,000
+0.5%
0.28%
-40.4%
Q1 2022$2,694,000
+19.1%
552,000
+176.0%
0.48%
+35.4%
Q4 2021$2,262,000
-11.3%
200,000
+14.3%
0.35%
-14.7%
Q3 2021$2,550,000
+25.1%
175,0000.0%0.41%
+34.4%
Q2 2021$2,039,000
+11.4%
175,000
+16.7%
0.31%
+97.4%
Q1 2021$1,830,000
+95.1%
150,000
+100.0%
0.16%
-14.8%
Q4 2020$938,000
-58.5%
75,000
-50.0%
0.18%
-54.7%
Q3 2020$2,258,000
-44.2%
150,000
-9.1%
0.40%
-43.5%
Q2 2020$4,044,000
+72.7%
165,0000.0%0.72%
+16.8%
Q1 2020$2,341,000
-10.6%
165,0000.0%0.61%
+47.5%
Q4 2019$2,619,000165,0000.42%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,510,282$7,370,0004.76%
SANDERS MORRIS HARRIS LLC 873,021$4,261,0000.83%
P.A.W. CAPITAL CORP 150,000$732,0000.76%
Nantahala Capital Management 2,244,359$10,952,0000.48%
Bleichroeder LP 552,000$2,694,0000.48%
APOGEM CAPITAL LLC 111,259$543,0000.37%
Slate Path Capital LP 1,483,619$7,240,0000.37%
Robertson Stephens Wealth Management, LLC 478,500$2,335,0000.20%
CARLSON CAPITAL L P 405,000$1,976,0000.14%
Bridgefront Capital, LLC 19,968$97,0000.12%
View complete list of CUE BIOPHARMA INC shareholders